Tempest Therapeutics Net Loss History
| TPST Stock | USD 2.29 0.13 6.02% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -25.5 M | Current Value -26.7 M | Quarterly Volatility 6.4 M |
Macro event markers
Among Tempest Therapeutics' reported metrics, Net Loss provides a view into a specific part of the financial picture. The most recent reading gains meaning when set against the full distribution of past values.
Latest Tempest Therapeutics' Net Loss Growth Pattern
Net Loss for Tempest Therapeutics moved from -25.5 M to -26.7 M over the most recent period. The most recent value of -26.7 M sits within a slightly volatile historical range. The curvature of Tempest Therapeutics' Net Loss trend adds context beyond what the raw numbers convey.
| Net Loss | 10 Years Trend |
|
All figures are presented for informational review.
Net Income Applicable To Common Shares |
| Timeline |
Net Loss Trend Statistics
| Arithmetic Mean | -19,310,776 | |
| Coefficient Of Variation | -33.29 | |
| Mean Deviation | 5,830,651 | |
| Median | -14,365,000 | |
| Standard Deviation | 6,428,538 | |
| Sample Variance | 41.3T | |
| Range | 13.9M | |
| R-Value | -0.84 | |
| Mean Square Error | 12.8T | |
| R-Squared | 0.71 | |
| Significance | 0.000022 | |
| Slope | -1,071,918 | |
| Total Sum of Squares | 661.2T |
Tempest Therapeutics Net Loss History
Methodology, Assumptions & Data Sources
Here is how Tempest Therapeutics's Net Loss has changed over time. Year-over-year changes are the easiest way to spot turning points.
The analytics block for Tempest Therapeutics relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Professional analyst research is incorporated when coverage is available. Timing can vary by data vendor. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.